HK1064042A1 - Medicines and medicinal kits - Google Patents

Medicines and medicinal kits

Info

Publication number
HK1064042A1
HK1064042A1 HK04106792A HK04106792A HK1064042A1 HK 1064042 A1 HK1064042 A1 HK 1064042A1 HK 04106792 A HK04106792 A HK 04106792A HK 04106792 A HK04106792 A HK 04106792A HK 1064042 A1 HK1064042 A1 HK 1064042A1
Authority
HK
Hong Kong
Prior art keywords
medicines
kits
medicinal
medicinal kits
Prior art date
Application number
HK04106792A
Other languages
English (en)
Inventor
Sahiro Orihashi
Junpei Koike
Kanako Masuda
Original Assignee
Kowa Co
Teika Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co, Teika Pharmaceutical Co Ltd filed Critical Kowa Co
Publication of HK1064042A1 publication Critical patent/HK1064042A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK04106792A 2001-04-19 2004-09-08 Medicines and medicinal kits HK1064042A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001121295 2001-04-19
PCT/JP2002/003292 WO2002085372A1 (fr) 2001-04-19 2002-04-02 Medicaments et trousses medicales

Publications (1)

Publication Number Publication Date
HK1064042A1 true HK1064042A1 (en) 2005-01-21

Family

ID=18971198

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106792A HK1064042A1 (en) 2001-04-19 2004-09-08 Medicines and medicinal kits

Country Status (8)

Country Link
US (1) US7816399B2 (ko)
EP (1) EP1386611A4 (ko)
JP (2) JP4261912B2 (ko)
KR (1) KR100875908B1 (ko)
CN (1) CN1259051C (ko)
BR (1) BR0209063A (ko)
HK (1) HK1064042A1 (ko)
WO (1) WO2002085372A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005068421A1 (en) 2004-01-05 2005-07-28 Nicox, S.A. Prostaglandin nitrooxyderivatives
JP2006298907A (ja) * 2005-03-22 2006-11-02 Teika Seiyaku Kk 点眼剤
KR20060102282A (ko) * 2005-03-22 2006-09-27 테이카 세이야쿠 가부시키가이샤 점안제
AU2007243765A1 (en) * 2006-03-29 2007-11-08 Nicox S.A. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
WO2011053801A2 (en) * 2009-10-30 2011-05-05 Intratus, Inc. Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
CA2860453C (en) * 2011-01-24 2020-04-28 Inceptum Research & Therapeutics, Inc. Compositions comprising a prostaglandin for treating neuropsychiatric conditions
WO2012169827A2 (ko) * 2011-06-08 2012-12-13 에스케이케미칼 주식회사 속눈썹 성장용 조성물
CN105263487B (zh) * 2013-04-18 2017-09-22 尼科斯科学爱尔兰公司 用于眼科应用的醌基一氧化氮供体化合物
CN105039358B (zh) * 2013-12-03 2020-02-28 北京康乐卫士生物技术股份有限公司 58型重组人乳头瘤病毒病毒样颗粒及其制备方法
ES2764654T3 (es) * 2014-11-19 2020-06-04 Nicox Sa Combinaciones de prostaglandinas y donantes de óxido nítrico
US10864609B2 (en) 2017-09-28 2020-12-15 Makita Corporation Dust collector
JP2021111280A (ja) * 2020-01-15 2021-08-02 キヤノン株式会社 相互認証ペアを形成する方法および認証装置
CA3166602A1 (en) 2020-02-05 2021-08-12 Nicoletta Almirante Compositions for the treatment of glaucoma and ocular hypertension

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
JPH11171764A (ja) * 1997-12-04 1999-06-29 Hiroshi Nagoshi レチノイド並びにプロスタグランジンｄ▲２▼誘導体の敗血症ショック治療薬としての使用
JPH11189537A (ja) * 1997-12-26 1999-07-13 Kyoto Pharmaceut Ind Ltd プロスタグランジン類の医薬用途
EP1142576B1 (en) * 1998-12-25 2005-03-02 Sucampo AG Drug compositions for the treatment of ocular hypertension or glaucoma
IL137429A0 (en) * 1999-07-28 2001-07-24 Pfizer Prod Inc Methods and compsitions for treating diseases and conditions of the eye
JP2001081048A (ja) * 1999-09-10 2001-03-27 Wakamoto Pharmaceut Co Ltd 眼圧降下剤
TWI290470B (en) * 1999-12-01 2007-12-01 Sankyo Co The composition for treating glaucoma

Also Published As

Publication number Publication date
BR0209063A (pt) 2004-08-10
JP2009137971A (ja) 2009-06-25
WO2002085372A1 (fr) 2002-10-31
US7816399B2 (en) 2010-10-19
KR20040007499A (ko) 2004-01-24
EP1386611A1 (en) 2004-02-04
CN1503674A (zh) 2004-06-09
EP1386611A4 (en) 2009-05-13
CN1259051C (zh) 2006-06-14
JP4261912B2 (ja) 2009-05-13
KR100875908B1 (ko) 2008-12-26
JPWO2002085372A1 (ja) 2004-08-05
US20040171681A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
GB0104534D0 (en) Pharmaceutical combination
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
HK1064042A1 (en) Medicines and medicinal kits
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
AU2002218502A1 (en) Lactam compounds and medicinal use thereof
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
GB0124523D0 (en) Pharmaceutical combination
EP1379228A4 (en) (Z) -STYRYLBENZYLSULPONES AND THEIR PHARMACEUTICAL APPLICATIONS
GB0119025D0 (en) Compounds and their therapeutic use
GB0129270D0 (en) Pharmaceutical combination
GB0115780D0 (en) Therapeutic molecules and uses thereof
GB0129397D0 (en) Pharmaceutical combination
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
GB0129395D0 (en) Pharmaceutical combination
AU2002243022A1 (en) Medicines and medicinal kits
GB0128138D0 (en) Pharmaceutical use
GB2376943B (en) Compounds and their therapeutic use
AU2001272552A1 (en) Oxygen-enriched agent and the use thereof for therapeutic purposes
AU2002323963A1 (en) Beta-ketoamide compounds and medicinal use thereof
AU2002237537A1 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160402